Profiel
Mr. Paul A. Howard is Founding Partner at Mediphase Venture Partners.
He is on the Board of Directors at Serenex, Inc.
Mr. Howard was a Senior Vice President at Hambrecht & Quist Capital Management in Boston from 1992-1999, where he was responsible for managing the fund's biotechnology investments.
From 1983-1990, he was a Senior Technical Sales Executive for the Miles Biotechnology Division of Bayer A.G.
Mr. Howard earned an AB from Bowdoin College in 1981, an MS from the University of Massachusetts, Amherst in 1983, and an S.M.
from the Sloan School of Management at M.I.T.
in 1992.
He serves on the Board of Directors of Supplemental Health Care and Serenex.
Actieve functies van Paul A. Howard
| Bedrijven | Functie | Begin |
|---|---|---|
Limulus Management Co. LLC
Limulus Management Co. LLC Investment ManagersFinance Limulus Management Co LLC invests in healthcare/life science companies located in the US. The firm focuses on companies with intellectual property positions and growth potential. It targets companies operating in the fields of biopharmaceutical technology and life sciences information. It provides financing for early stage capital requirements with an investment size ranging from $4 to $8 million. | Oprichter | 03-01-2011 |
Wellpartner LLC
Wellpartner LLC Medical DistributorsDistribution Services Provides pharmacy distribution solutions and contract pharmacy administration services | Directeur/Bestuurslid | - |
Eerdere bekende functies van Paul A. Howard
| Bedrijven | Functie | Einde |
|---|---|---|
Tekla Capital Management LLC
Tekla Capital Management LLC Investment ManagersFinance Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries. | Portefeuillebeheerder-Aandelen | 31-12-1998 |
Bayer AG /Plasma Products Business/
Bayer AG /Plasma Products Business/ Pharmaceuticals: MajorHealth Technology Provides plasma products | Corporate Officer/Principal | 31-12-1989 |
| TETRAPHASE PHARMACEUTICALS, INC. | Directeur/Bestuurslid | - |
Serenex, Inc.
Serenex, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs | Directeur/Bestuurslid | - |
Opleiding van Paul A. Howard
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Serenex, Inc.
Serenex, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs | Health Technology |
Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
Tekla Capital Management LLC
Tekla Capital Management LLC Investment ManagersFinance Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries. | Finance |
Wellpartner LLC
Wellpartner LLC Medical DistributorsDistribution Services Provides pharmacy distribution solutions and contract pharmacy administration services | Distribution Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Bowdoin College
Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer AG /Plasma Products Business/
Bayer AG /Plasma Products Business/ Pharmaceuticals: MajorHealth Technology Provides plasma products | Health Technology |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Limulus Management Co. LLC
Limulus Management Co. LLC Investment ManagersFinance Limulus Management Co LLC invests in healthcare/life science companies located in the US. The firm focuses on companies with intellectual property positions and growth potential. It targets companies operating in the fields of biopharmaceutical technology and life sciences information. It provides financing for early stage capital requirements with an investment size ranging from $4 to $8 million. | Finance |
















